DR. LAL PATH LABS LTD. Fair Value
LALPATHLAB · Healthcare · Current price ₹1,900.7
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹355 | 23% ROE fading to 12% over ~20 yrs, on ₹150 book |
| Relative P/E | ₹1,949 | EPS × 64.7 peer-median P/E |
| Graham floor | ₹319 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹1,959 | Street consensus 12-month target price |
Is DR. LAL PATH LABS LTD. undervalued?
DocStoX estimates the fair value of DR. LAL PATH LABS LTD. at ₹1,006 per share, versus the current market price of ₹1,901. That puts the stock about -47.1% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹355), Relative P/E (₹1,949), Graham floor (₹319), Analyst target (₹1,959). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹319 (bear) to ₹1,006 (base) to ₹1,959 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on DR. LAL PATH LABS LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.